作者xchair (我沒有腐敗的資格!!)
看板NTUIB92
標題湯明哲的併購case2 問題
時間Wed Mar 12 01:42:48 2003
大家應該都有收到吧 還是貼一下囉:)
Dear All:
The discussion questions of the Merck case are the following:
1. What was the rationale for PBMs?
2. Does Medco fit with Merck's strategy?
3. What does Medco bring to Merck? What are the advantages and disadvantages?
4. What does Medco get from Merck's acquisition?
5. Is health management the future?
You do not have to answer every question. Just show a thorough, and well thought analysis. Be critical.
Best regards,
Professor Tang
--------
One more question on the Merck case.
Did Merck pay too much?
You can have all kinds of assumptions.
Good luck!
Professor Tang
--
※ 發信站: 批踢踢實業坊(ptt.csie.ntu.edu.tw)
◆ From: 140.112.228.35
※ 編輯: xchair 來自: 140.112.228.35 (03/12 01:55)